These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9730725)

  • 1. Hemolytic uremic syndrome associated with beta-interferon therapy for chronic hepatitis C.
    Ubara Y; Hara S; Takedatu H; Katori H; Yamada K; Yoshihara K; Matsushita Y; Yokoyama K; Takemoto F; Yamada A; Takagawa R; Endo Y; Hara M; Koida I; Kumada H
    Nephron; 1998 Sep; 80(1):107-8. PubMed ID: 9730725
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief Review and a Clinical Case of Hemolytic Uremic Syndrome Associated with Interferon β Treatment.
    Milan Manani S; Virzì GM; Gastaldon F; Proglio M; Brocca A; Ronco C
    Blood Purif; 2017; 43(1-3):136-143. PubMed ID: 27951532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent hemolytic uremic syndrome in the renal allograft.
    Nasr SH; Brouder D; Haider N; Markowitz GS
    Kidney Int; 2006 Mar; 69(6):949. PubMed ID: 16528238
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic plasma exchange in Streptococcus pneumoniae-associated hemolytic uremic syndrome: a case report.
    Petras ML; Dunbar NM; Filiano JJ; Braga MS; Chobanian MC; Szczepiorkowski ZM
    J Clin Apher; 2012; 27(4):212-4. PubMed ID: 22307916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β.
    Larochelle C; Grand'maison F; Bernier GP; Latour M; Cailhier JF; Prat A
    Mult Scler; 2014 Nov; 20(13):1783-7. PubMed ID: 24534079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Purpura due to vasculitis induced by interferon therapy for a patient with chronic hepatitis type C].
    Toubai T; Akama H; Tabata N; Uno K; Kitami M; Takagawa M; Fukuda M; Chiba J; Arakawa M; Ishida S; Sasaki Y
    Nihon Naika Gakkai Zasshi; 2001 Jul; 90(7):1330-2. PubMed ID: 11519113
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome relapse: frequency, pathogenesis, and meaning.
    Bell WR
    Semin Hematol; 1997 Apr; 34(2):134-9. PubMed ID: 9109215
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolytic uremic syndrome presenting as hepatitis.
    Furgiuele TL
    Tex Med; 1981 Aug; 77(8):55-6. PubMed ID: 7268646
    [No Abstract]   [Full Text] [Related]  

  • 9. Consequences of hemolytic uremic syndrome among hemodialysis patients.
    Brunelli SM; Claxton A; Mehta S; Anum EA
    J Nephrol; 2015 Jun; 28(3):361-7. PubMed ID: 25491936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin.
    Banerjee D; Kupin W; Roth D
    J Nephrol; 2003; 16(5):733-5. PubMed ID: 14733422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolytic uremic syndrome].
    Nakajima M; Yoshioka A
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):929-33. PubMed ID: 9340359
    [No Abstract]   [Full Text] [Related]  

  • 12. The interferon system in two patients with hemolytic uremic syndrome associated with adenovirus infection.
    Blachar Y; Leibovitz E; Levin S
    Acta Paediatr Scand; 1990 Jan; 79(1):108-9. PubMed ID: 1690496
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of chronic hepatitis C with interferon-induced retinopathy worsen after termination of treatment].
    Numata M; Matsumoto Y; Ochiai T; Matsuoka H; Kuribayashi T; Ido A; Hayashi K; Tsubouchi H
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):62-5. PubMed ID: 12601931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic and intensive care problems in hemolytic uremic syndrome].
    Menges M; Bissinger KR; Krieger G; Hack G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Oct; 29(6):375-8. PubMed ID: 7999945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic-uremic syndromes (microangiopathic hemolytic anemias)].
    Judkiewicz L
    Pol Tyg Lek; 1975 Sep; 30(39):1629-31. PubMed ID: 1103099
    [No Abstract]   [Full Text] [Related]  

  • 17. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
    N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome associated with emphysematous cholecystitis.
    Babott D; Brozinsky S; Esseesse I; Suster B
    Am J Gastroenterol; 1980 Mar; 73(3):252-6. PubMed ID: 7405926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
    Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
    Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolytic-uremic syndrome in adults].
    Verbanck J; Bogaerts Y; Baele G; Praet M; Lameire N; Bernard R
    Acta Clin Belg; 1979; 34(6):344-52. PubMed ID: 233397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.